Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Monopar Therapeutics Inc. (MNPR)

70.32 -1.59 (-2.21%)
At close: October 30 at 4:00:01 PM EDT
70.32 0.00 (0.00%)
After hours: October 30 at 4:00:06 PM EDT
Trade MNPR on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
22,118.22
16,704.42
16,161.72
8,831.24
10,536.88
Operating Income
-22,118.22
-16,704.42
-16,161.72
-8,831.24
-10,536.88
Net Non Operating Interest Income Expense
4,241.32
2,987.52
404.02
429.04
21.24
Other Income Expense
--
--
171.28
--
--
Pretax Income
-17,844.75
-13,716.89
-15,586.42
-8,402.20
-10,515.64
Net Income Common Stockholders
-17,844.75
-13,716.89
-15,586.42
-8,402.20
-10,515.64
Diluted NI Available to Com Stockholders
-17,844.75
-13,716.89
-15,586.42
-8,402.20
-10,515.64
Basic EPS
-2.20
-1.85
-4.11
-3.04
-4.15
Diluted EPS
-2.20
-1.85
-4.11
-3.04
-4.15
Basic Average Shares
8,184.22
7,411.12
3,790.20
2,764.79
2,543.63
Diluted Average Shares
8,184.22
7,411.12
3,790.20
2,764.79
2,543.63
Total Operating Income as Reported
-22,118.22
-16,704.42
-16,161.72
-8,831.24
-10,536.88
Total Expenses
22,118.22
16,704.42
16,161.72
8,831.24
10,536.88
Net Income from Continuing & Discontinued Operation
-17,844.75
-13,716.89
-15,586.42
-8,402.20
-10,515.64
Normalized Income
-17,844.75
-13,716.89
-15,586.42
-8,402.20
-10,515.64
Interest Income
4,241.32
2,987.52
404.02
429.04
21.24
Net Interest Income
4,241.32
2,987.52
404.02
429.04
21.24
EBIT
-22,118.22
-16,704.42
-16,161.72
-8,831.24
-10,536.88
EBITDA
-22,118.22
-16,704.42
-16,161.72
-8,831.24
-10,536.88
Net Income from Continuing Operation Net Minority Interest
-17,844.75
-13,716.89
-15,586.42
-8,402.20
-10,515.64
Normalized EBITDA
-22,118.22
-16,704.42
-16,161.72
-8,831.24
-10,536.88
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/19/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: